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Abstract
Background: Municipal drinking water contaminated with the parasite Giardia lamblia in Bergen, Norway, in 2004
caused an outbreak of gastrointestinal infection in 2500 people, according to the Norwegian Prescription Database.
In the aftermath a minor group subsequently developed post-infectious fatigue syndrome (PIFS). Persons in this
minor group had laboratory-confirmed parasites in their stool samples, and their enteritis had been cured by one or
more courses of antibiotic treatment. The study’s purpose was to explore how the affected persons experienced
the illness trajectory and various PIFS disabilities.
Methods: A qualitative design with in-depth interviews was used to obtain first-hand experiences of PIFS. To get
an overall understanding of their perceived illness trajectory, the participants were asked to retrospectively rate their
functional level at different points in time. A maximum variation sample of adults diagnosed with PIFS according to
the international 1994 criteria was recruited from a cohort of persons diagnosed with PIFS at a tertiary Neurology
Outpatient Clinic in Western Norway. The sample comprised 19 women and seven men (mean age 41 years, range
26–59). The interviews were fully transcribed and subjected to a qualitative content analysis.
Results: All participants had been living healthy lives pre-illness. The time to develop PIFS varied. Multiple disabilities in
the physical, cognitive, emotional, neurological, sleep and intolerance domains were described. Everyone more or less
dropped out from studies or work, and few needed to be taken care of during the worst period. The severity of these
disabilities varied among the participants and during the illness phases. Despite individual variations, an overall pattern
of illness trajectory emerged. Five phases were identified: prodromal, downward, turning, upward and chronic phase.
All reached a nadir followed by varying degrees of improvement in their functional ability. None regained pre-illness
health or personal and professional abilities.
Conclusions: The needs of persons with this condition are not met. Early diagnosis and interdisciplinary rehabilitation
could be beneficial in altering the downward trajectory at an earlier stage, avoiding the most severe disability and
optimising improvement. Enhanced knowledge among health professionals, tailored treatment, rest as needed,
financial support and practical help would likely improve prognosis.
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Background
In 2004, the parasite Giardia lamblia contaminated the
municipal drinking water reservoir supplying a part of
Bergen City, Norway, due to a leakage of faecal matter
from a sewer pipe [1–3]. Giardia l. is endemic in many
countries globally, but not in Norway [2]. This parasite
induces enteritis, a diarrhoeal disease [3]. One of the two
waterworks supplying tap water to the city, Svartediket,
supplies 52.000 inhabitants. People who lived, worked or
had stayed in that part of the city during the outbreak
were exposed to the contaminated water. A report esti-
mated that between five to six thousand people were in-
fected [1]. The laboratory at Haukeland University
Hospital identified the total of 1262 cases of confirmed
Giardia l. parasites in stool samples [4]. According to the
Norwegian Prescription Database more than 2500 persons
with Giardia duodenalis were treated with antibiotics fol-
lowing the outbreak [2]. Most were women and younger
persons. The only predictor for falling ill was drinking
more than five glasses of contaminated water daily [2, 5].
Antibiotics cured the infection, but many affected individ-
uals developed persistent tiredness and irritable bowel
syndrome (IBS) [6, 7]. A minor group developed debilitat-
ing fatigue and was subsequently referred to the hospital’s
Outpatient Neurology Clinic from August 2005 to
September 2007 with suspicion of post-infectious fatigue
syndrome (PIFS) [4].
The term PIFS refers to severe and prolonged fatigue
following infectious triggers [8], such as viruses [9],
bacteria [10] and parasites [4]. Because infectious agents
are not always objectively established, the terms post-viral
fatigue syndrome (PVFS) [11] and myalgic encephalomy-
elitis (ME) [12] have also been used for this condition. For
convenience the term PIFS will be used hereafter. The
most frequent onset is acute [13]. Within days or weeks of
the initiating infectious trigger, which is termed the
prodromal phase, the affected individuals experience a
progressive decline in functional ability. A minor group
has a more gradual or insidious onset, and the decline
may take many months or years. In both cases, the decline
in health is followed by the emergence of numerous new
symptoms from different body systems. The fatigue must
have resulted in a 50% reduction in functional level com-
pared with pre-illness and have persisted for more than
six months in order to define it as PIFS [13, 14]. Rapid fat-
igability, pain, neurological complaints and autonomic
and immunological dysfunction are prominent features.
Most characteristic is post-exertional malaise (PEM) man-
ifested as symptom exacerbation followed by increased
disability induced by any kind of physical, cognitive or
emotional exertion. This exacerbation and the increased
illness burden can last for weeks [15, 16]. Although patho-
logic mechanisms [12] such as dysfunctions in the
immune system [17, 18] and neuroendocrine system [19],
chronic inflammation [20], an increase in gene expression
following exercise [21] and brain inflammation [22] are
found, the aetiology remains unclear. A heritable predis-
position is suggested [23]. No cure is currently available;
therefore, treatment aims at alleviating symptoms and
fostering the mastery of challenges in daily life to improve
functioning [24–26]. A review of natural courses found
that complete recovery is rare [27] - less than 10% - but
that the odds for improvement of symptoms may be more
favourable. The frequency of resuming work ranges from
8–52% [27] and for living on disability benefits 25–42%
[28, 29]. Even individuals who claim to have recovered are
unable to resume pre-illness activity levels [30]. Individ-
uals with PIFS experience multiple functional losses and
disabilities as a result of the illness. The disabilities may be
permanent, chronic, episodic or fluctuating in nature.
Population-based prevalence is around 0.4% [31].
The illness course and its phases are also worth
exploring, because knowledge in this area may offer
insights for a better approach to understanding this
chronic condition and identifying the challenges in each
phase, which could further the development of more
appropriate phase-specific treatments. When taking into
account the relapsing and remitting nature of PIFS [13],
a model of discrete and hierarchical stages that presup-
poses succeeding and fixed stages seems inappropriate.
A previously described model for understanding the
phases in clinical practice is the Fennell Phase Inventory
(FPI) [32]. The FPI comprises four phases termed Crisis,
Stabilisation, Resolution and Integration, and it focuses
on the ways that affected individuals cope during each
phase. It is progressive, but flexible, attempting to capture
the condition over time, allowing for overlap between
phases, regression to an earlier phase or being in more
than one phase at a given time [33]. Previous quantitative
research has explored the FPI phases and found support
for its use [33–36]. However, the personal experience of
disability that accompanies the transition from good
health to contracting an infection and subsequently living
with PIFS has not been explored empirically. Thus, a
model to understand the illness phases and fluctuations in
functional level is needed. General practitioners (GPs)
may feel uncomfortable in making the diagnosis or defin-
ing the condition [37], and health professionals have a
limited understanding of it [38]. Because appropriate ad-
vice and support from health care professionals may vary
during the illness trajectory, there is a need to understand
how the disabilities are experienced in different phases
and how the severity of different disabilities is experienced
by the persons affected. The purpose of our study was to
increase our understanding of how the participants expe-
rienced the evolvement of their illness trajectory from the
onset of the Giardia l. enteritis and over the subsequent
four years when looking back on their experiences.
Stormorken et al. BMC Family Practice  (2017) 18:49 Page 2 of 15
Method
Design
This study had a retrospective explorative qualitative de-
sign [39, 40]. We employed in-depth qualitative interviews
to gain access to the participants’ experiences and con-
ducted an inductive qualitative content analysis [41].
Sample
Among severely fatigued individuals referred to the
Outpatient Neurology Clinic [4] a cohort of laboratory
confirmed Giardia l. parasites in their stool samples was
diagnosed with PIFS by a neurologist according to inter-
national criteria [14]. This Giardia PIFS cohort, that is,
the population, accounted for five percent of the total
number of laboratory confirmed cases [4]. Four years after
the outbreak in 2004, the interview sample was derived
from this cohort of 58 ethnic Caucasian Norwegians [4].
A request for participation, consent form, questionnaires
regarding demographic and socioeconomic variables,
number of signs and symptoms [42] [see Additional file
1], and Bell’s Disability Scale to retrospectively record
functional level at different points in time [43] [see Add-
itional file 2], were administered from the outpatient clinic
to the Giardia cohort in January 2008. Forty-four patients
(76%) answered the questionnaires. Based on differences
in gender, age, education level, income, work/study status,
symptom burden, and functional level, we selected a
maximum variation sample of 26 persons among those 44
who had returned the questionnaires [44]. We then con-
tacted 19 women and seven men for an in-depth qualita-
tive interview. None of the invited participants who
consented to being interviewed withdrew. Mean age for
the sample was 40.9 (range 26–59), whereas mean age for
women was 41.4 years (range 26-59) and for men 39.5
years (range 26–58). Twelve were single, nine married,
two cohabiting and three divorced. Education level varied:
two had completed their education up through junior high
school, four through senior high school, six through their
college/university undergraduate degree and 14 through
their college/university graduate degrees. Prior to the
Giardia duodenalis infection, all were engaged full time in
work or studies. The number of symptoms from various
body systems [42] ranged from 14 to 70 (median 36). In
the questionnaire the participants were asked to describe
the household income according to five categories: Four
perceived themselves to have very low income, eight low,
nine average, six high and one very high three months
before the interview. Some reported full symptomatic
recoveries from their Giardia d. infection; however, 19 (14
women and 4 men) continued to have symptoms of
irritable bowel syndrome (IBS). Sixteen (12 women and 4
men, 61.5%) reported having received a physician-
confirmed diagnosis of post-infectious IBS. None had IBS
prior to the Giardia enteritis. In addition to in-depth
interviews, the participants were asked to retrospectively
rate their ability to function on Bell’s Disability Scale [43]
[see Additional file 2], a clinical measure recommended
for use in primary care [45] and used in other studies [46,
47] (see the Result section). The purpose of this was to get
an overall understanding of their functional abilities
during the course of their illness.
Procedure
To reduce the effort of participation, we conducted the
in-depth interviews prior to a scheduled follow-up
appointment at the Outpatient Neurology Clinic, four
years after the Giardia outbreak. All interviews were
audiotaped and lasted from one to two hours (mean 1.5
h). The aim of the interview was to explore the partici-
pants’ personal experiences. An interview guide [see
Additional file 3] derived from previous research and
clinical experience was used to ensure that all partici-
pants conveyed their experiences in the same areas. The
opening question was “Please tell me about your life,
from being healthy in the spring of 2004 until today”.
Follow-up questions and prompts were used to explore
their experiences in more depth, for example: “Please
describe how the condition has influenced your work,
studies, leisure activities or everyday life during the tra-
jectory”. To further explore the experiences, the follow-
ing prompts were used: “Can you elaborate on specific
incidents or provide examples of how your functional
level affected your everyday life”?
Data analysis
As a first step, the transcripts were read multiple times
to obtain a preliminary understanding of the partici-
pants’ experiences and the context [48]. During this
initial exploration of the interview data we observed that
the participants described a fluctuating illness trajectory.
In addition we noted a pattern of fluctuations in various
functional disabilities. We then used NVivo 10 software
[49] to extract material pertaining to the research
question, including sentences and text passages [50]. As
the second step we used a manual inductive analytic
approach to the extracted text to avoid preconceived
categories [51, 52]. Upon reading the extracted text,
notes and open codes were written down in the margins
[50]. In the first coding cycle [53], meaning units emer-
ging freely from the text were given descriptive code
labels (Table 1).
During the second coding cycle [50], we sorted coded
text into mutual exclusive categories and sub-categories
(Table 2).
We revised the categories and sub-categories several
times to ensure that the illness trajectory and various
disabilities reflected the participants’ experiences [50],
and ended up with five different phases. The prodromal
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phase was described as the phase from falling ill with
Giardia l. infection until developing symptoms charac-
teristic of PIFS, whereas the subsequent four phases de-
scribed the experienced trajectory of PIFS. An example
of functional ability associated with each of the five
emergent illness phases is provided (Table 3).
Our data-driven analysis revealed overall iterative pat-
terns of illness trajectory and disabilities.
Trustworthiness
Guba and Lincoln’s five criteria for assessing the quality
of naturalistic research [39, 54], credibility, dependabil-
ity, conformability, transferability and authenticity were
used to ensure trustworthiness [55]. To ensure credibil-
ity [39], we selected a maximum variation sample to
capture the range and variations of first-hand illness ex-
periences [44, 56, 57]. The interviews had open-ended
questions, allowing the participants to speak freely, using
their own logic [44]. Saturation was reached as no new
concepts emerged regarding the illness trajectory and
disabilities after reading and interpreting several inter-
views. Dependability [39] was ensured by conducting the
interviews in a conversation-like manner to establish
rapport, and unclear statements were asked to be
clarified. The interviewer strove to listen attentively with
an open mind [58]. Field notes were recorded immedi-
ately after each interview [40]. Content analysis was used
to reduce the large amounts of interview texts [51],
whereas NVivo was used for a manual and inductive
analysis of the transcribed interviews. Paragraphs were
coded in NVivo for a subsequent manual analysis of ex-
tracted material. Transcripts were used as the standard
to check the data analysis and the interpretations against
[39]. A reflexive journal was used throughout the study
[59, 60] to reduce researcher bias [61]. The first author
conducted all the interviews, transcribed the audio-
recordings and checked for consistency between audio
recordings and transcripts. This author is a registered
nurse with long professional experience with this patient
group. Professional and personal experience with the
condition constituted the first author’s preconception
[62], which was reflected on before enrolment [63] and
throughout the study. The second author is an experi-
enced researcher in the field, and the third author’s pre-
conception was influenced by previous research in other
disease populations, including some experience with
PIFS. Confirmability [39] was ensured by authors one
and three reading the interviews, extracting data and
coding separately [55]. Disagreements on the interpret-
ation of meaning units, code labels and categories were
discussed until agreement was reached. The second
author read the final result section and agreed to the
findings. We assigned quotes from different participants
to sub-categories and used triangulation of investigators,
and methods, using in-depth interview and Bells’
Disability Scale. Each method corroborated the other
regarding the phased trajectory. Transferability [39] was
sought by providing detailed descriptions of all aspects
of the study, helping readers to judge whether the find-
ings would be applicable in other contexts. To ensure
authenticity [54], the findings reflect multiple realities
and differences in functional ability at each phase of the
trajectory.
Ethical consideration
Request letters were sent to the Giardia PIFS cohort of
58 persons. Due to project limitations, not all could be
included. Thus, the selection procedure was explained in
the letter [64]. Information that could compromise iden-
tity was removed from the data. Because the sample was
local, small and specific we could not reveal the profes-
sional status and therefore had to use a system of aggre-
gate professional titles [65]. Interviewing vulnerable
participants may provoke distress, and the interviewer
verbally obtained renewed consent when emotional reac-
tions such as crying spells occurred. Measures were
taken to minimise any inconvenience and reduce harm.
The interview room was quiet and dimly lit. When
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lines of thoughts
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stamina
• Easy cognitive fatigability
• Lack of cognitive stamina
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increased fatigue was observed, participants were asked
if they wanted to stop, but all declined. Interviews were
terminated when necessary. The principles of the
Declaration of Helsinki were followed throughout the
study [66].
Results
The participants’ accounts revealed an illness trajectory
comprising five phases over the four-year period: 1) the
prodromal phase following the enteritis, 2) the down-
ward phase - the development of PIFS and a decline in
functional abilities, 3) the turning phase - the most se-
vere disabilities, a phase of illness turning, 4) the upward
phase - improvement in various degrees, and 5) the
chronic phase - stabilization for some participants,
further improvement for others and an new decline for a
few Fig. 1.
The transition between the different illness phases was
imperceptible, but for clarity, the illness trajectory is
divided into five overlapping phases. How long the
individual participant experienced being in each phase
varied, but cannot be specified in detail due to the retro-
spective design of this study.
The five phases of the illness trajectory
Phase 1: experiences of the prodromal phase and the
transition into PIFS
Before the infection, they lived ordinary lives, worked
or studied full time, travelled, enjoyed cultural life
and were physically active, a life comparable with
healthy people’s lives: “Before I got ill I worked
100%… was engaged in leisure time activities twice a
week… always something going on… was very active,
exercised” (P7). At the onset of the infection, the
participants perceived it as a “normal” stomach
disease expected to pass after a few days. However,
the symptoms persisted from months to a year and
included diarrhoea, nausea, stomach-aches and
cramps, flatulence, muscle and joint pain, headaches
and food intolerances:
[P]ain in the joints, headache, muscles and stomach…
whole body is aching. A terrible foul-smelling stool…
bloating… farting and burping all the time… 24 hours
for one year (P10); I couldn’t tolerate eating anything.
The kilos vanished (P7).
The largest reported weight loss was 27 k. The
participants experienced a cyclic pattern and related
their tiredness to the infection and running to the
toilet:
You didn’t have it day in and day out. These parasites
lay eggs inside us, so they have this cycle… was
healthy for five days and thought it had passed, but
after five, four, three days, another wave [of diarrhoea
and stomach cramps] occurred… became increasingly
tired (P2).
Table 3 Example of functional ability and the emerged illness trajectory
Category Illness trajectory
Sub-categories Trajectory phases
Prodromal Downward Turning Upward Chronic
Category
Functional ability “Only fourteen days after I
got Giardia… I was knocked
out”









“Now it is fifty-fifty for me,
working 50%… 50% welfare
benefits”
Fig. 1 Illness trajectory phases as experienced by the participants
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It took a long time before they were diagnosed with
Giardia d. and treated, and many needed more than one
course of antibiotics and had to have their stool re-
examined:
[It took a] long [time] before [blood and stool]
samples were taken… long time before I got
medication (P1); I had Giardia in 2004, September-
October, and I had three courses [of antibiotics] and
completed the treatment in January 2005 (P13).
Although the Giardia d. infection was cured, the
affected individuals did not fully recover as expected:
“The parasite disappeared from the body, gone, but the
other symptoms didn’t” (P25). A few described a rapid
development of severe fatigue over a couple of weeks,
some more gradual over months, whereas others
described a slow decline in functional ability over years.
The tiredness developed almost imperceptibly into pro-
found fatigue:
[O]nly 14 days after I got the Giardia [October
2004]… [I was] knocked down almost immediately
(P15); [It] just happened insidiously. In June 2006 I
threw in the towel (P18); [It] started as energy
[failure]… worst period in February 2007 (P17).
The participants experienced a worsening of fatigue
when gastrointestinal (GI) symptoms increased and vice
versa, suggesting the whole body system was involved in
a vicious circle:
PIFS and [giardiasis] stomach, the one amplifies the
other. If I feel ill, the stomach upset gets worse. If I
overexert myself, then the whole system gets [worse].
It’s a little bit difficult to distinguish Giardia [from
PIFS]… there is a correlation… it becomes a vicious
circle (P1).
Phase 2: experiences of the downward phase of PIFS
The participants described the downward phase as a con-
tinuous decline in disability levels in all areas. Physical,
cognitive, emotional, social and vocational exertions pro-
voked symptom flare-ups. They experienced a dramatic
change in health and had never experienced anything like
it before:
It’s dramatic to go from being healthy to being like
this (P23); Never, ever experienced anything like
this (P18).
They felt their bodies were like an engine slowing
down and failing: “I got worn out faster, like an engine
that runs slower and slower and then it stops” (P26).
There was a steady increase in new symptoms from sev-
eral body systems and increasing symptom intensity:
At that time I had steadily growing symptoms (P23);
[I] started to get pain everywhere (P10); I've lost my
potency (P6).
Their physical functional ability and stamina severely
declined. A few became bedridden or housebound. For
others, it was difficult to walk short distances, even with
breaks. Physical capacity was poor, and restitution time
prolonged:
I gradually got worse until I just collapsed, bedridden.
In January 2006 I had the final collapse… completely
finished, exhausted, sick (P23); If I walked a short
distance, I needed several stops (P16); [I had] very
poor capacity (P26).
They also experienced decreasing cognitive ability
resulting in concentration problems, difficulties with
word-finding, disrupted trains of thought, reduced
short-term memory and memory loss, and remembering
names or faces. Their brains were perceived as “out of
order”, making cognitive tasks difficult to perform:
[I] became disoriented and unable to collect my
thoughts and concentrate [2005]… a layer is covering
the head and the body and you notice that the brain
actually doesn’t work as it used to… We’ve lived in
our bodies for many years, so we know how things
should be (P23).
The decreasing functional ability and increasing symp-
tom burden, the insecurity and guilty conscience were
very energy-draining and added to their burden:
Mom is sick, Mom is sick and she is sick all the time.
It affects you emotionally… no desire to be a bad
mother… I thought I was going to die, perish at a
time when I was very ill (P10).
Some were frightened or thought they might die; some
were concerned that they had not done what was best
for them:
When you don’t receive information, when things are
wrong, you become afraid: ‘Am I making mistakes?
Am I taking a wrong step? Should I do this? Should I
do that? (P11).
The participants started to experience intolerances to
alcohol and foods as well as sensory and neurological
symptoms:
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[S]ymptoms appeared… didn’t tolerate noise, light,
no sensory input at all (P9); There is a great deal of
foods I can’t tolerate (P13); I started to get pain in my
eyes (P10); My body started to drag somewhat to the
side (P1).
They experienced that their bodies were hard to
control, and pushed themselves beyond their bodies’
capacity, both in personal and professional life. This led
to further decline in functional ability:
I’m unable to control [my body] (P1); I was very good
at pushing myself. I can see that in retrospect (P9);
I worked first 100%, then 50%, then, I crashed against
the wall, quite simply (P4).
During the downward phase, the participants de-
scribed a clear pattern of fluctuating and declining
work or study capacity, and many dropped out tem-
porarily or permanently: “I came to a complete halt…
didn’t function any more in April 2006” (P26). After
realising that they were no longer able to work or
study full time, they had to take sick leave. Following
rest and reduced work/study load, many participants
felt they were less disabled and fit enough to resume
prior engagements, only to realise they had overesti-
mated themselves again, and even got worse. This
was a time of trial and error to find out what their
bodies could tolerate without symptom flare-ups and
increased disability:
To see the GP to be granted a longer sick leave
was so emotionally demanding that I couldn’t get
myself to do it… pushed me back to work 100%
from January until October. In October I was
granted sick leave again, worked 80 and 20% sick
leave… after a while I realised that I didn’t have
the capacity to do that… reduced to 50% work and
50% sick leave, then 40% work and 60% sick leave.
If I push myself a little more than I can tolerate,
I collapse. Late summer [2007] I worked 40%, in
August I had 100% sick leave… I haven’t been
working since February 2008 (P7).
Many struggled to obtain welfare benefits and to comply
with the demands of the social security system. This was
an on-going issue and an additional energy-draining
process:
I submitted the application for rehabilitation
benefits. Finally, I received a decision after a good
deal of fuss. The payments were supposed to
happen every month, but they didn’t. Yes, it was a
full-blown financial crisis (P1).
Some described a period of hypersomnia; that is, they
slept for abnormally long periods or were more or less
in a state “beyond time” for hours or through night and
day. They could suddenly fall asleep without noticing
what was going on around them. This hypersomnia
period could last for weeks or several months:
I fell asleep on duty and woke up several hours later
(P18); I could sleep with 30 people around me (P19);
I slept for five months (P26).
Social and cultural participation became increasingly
more difficult due to profound fatigue, lack of energy
and stamina, making individuals unable to make contact
or maintain relationships: “I slept for 12–14 h… social
life… didn’t exist” (P4).
Phase 3: experiences of the turning phase of PIFS – the
worst phase
The downward trajectory eased and reached a plateau.
The disability level, varying among the participants, was
at its nadir during the turning phase. Most of the partic-
ipants were still able to take care of personal needs or
household chores at this time, but not all:
My spouse had to wash my hair, give me a bath,
dry me off and put me to bed (P8); I stayed a long
time with Mom and Dad… got my meals served to
me (P16).
One of the most disabled participants described
spending a year almost bedridden or housebound and
was monitored for a long time and taken care of by fam-
ily members:
I spent all of 2005 in bed. I couldn’t really take care of
myself… stayed with my sister so I could survive. At
your worst you need help with everything… just the
opportunity to exist, because you’re unable to take
care of yourself. My mother sat by my side and
monitored me (P11).
Other severely affected participants were able to sit
upright for some hours: “[U]sually up every single day, a
few hours” (P17) but needed to rest a lot of the time:
Most of the time I was lying on the couch (P9); If
I went up a flight of stairs, the muscles stopped
working (P23); [E]mptying the dishwasher could
take an hour… breaks in between… I dreaded to
start something… such as making dinner, only got
halfway through dinner, then I had to lie down
and rest (P9); I fainted in the shower, without
warning (P4).
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The participants experienced severely impaired cogni-
tive function during the worst period, but to varying de-
grees. They experienced little or no intellectual capacity
and struggled with severe memory loss and concentra-
tion difficulties and even an inability to think at all. In
the less severely ill, cognitive abilities were less impaired,
and they were able to function at home but unable to
work or study:
[I] just sat in a chair… stared into space (P26); If I
received a message, nothing happened inside my
brain, couldn’t even think. I don’t have any
recollection of 2005 (P11); I couldn’t read Donald
Duck (P16); [M]y head… nothing in there but a heap
of cotton. It’s empty (P22).
At the nadir, energy levels seemed too low to
produce psychological worries in some participants, as
they experienced profound fatigue and a state of
mind “beyond time.” Hours could pass completely
unnoticed:
Time’s passing. If it is one hour or seven hours…
don’t notice (P15); I felt it was like a coma… the
concept of time disappeared completely (P19).
The sensory symptoms and symptom intensity were
described as being at their worst. The intolerances to
foods, light, noise and alcohol had increased to such a
degree that participants had to stop drinking alcohol
and avoid or minimise factors that provoked the
intolerances:
From the time I was affected with Giardia, I think I
almost haven’t tasted alcohol. If I had a beer, I became
exhausted and fatigued. So I stopped completely
(P16); [I] couldn’t even tolerate sound or music (P26);
I put on my sunglasses which really are covering and
shutting out the light, and I am putting my cap on if
I’m going to leave the house (P21).
Neurological symptoms were also described to be at
their worst and comprised balancing difficulties, inability
to walk a straight line, veering to one side, tingling and
paraesthesia, vision problems and pain in the eyes, joints
and muscles:
I staggered in the bathroom, didn’t have balance…
leaned myself towards the wall… unable to walk a
straight line. [A]lmost double vision (P23); Unsteady
gait… veered a little to one side… the vision was
weird, in relation to the midline (P1). [P]ain in the
joints… pain everywhere, excruciating pain, migrating
pain (P10).
The students had dropped out, and none were able to
work full time. Those who were able to work part time
needed recurrent periods of sick leave to rest in order to
manage working at all. Sickness absence lasted from
weeks to several months or years:
From the autumn of 2005 until spring of 2006 I did
not study [at all] (P16); I never actually got better…
just a little compared with the worst period… did not
even think about [resuming my studies] (P23);
February 2007 I took sick leave from work for three
months (P17).
The profound fatigue, high symptom burden, easy fat-
igability, lack of energy and stamina and PEM following
minimal exertions made it difficult to have a social life.
The participants needed to withdraw from or limit
cultural activities and social interaction:
The fatigue has an all-encompassing consequence for
absolutely everything. I just disappeared from everyone
(P23); I’ve been at home half a year… haven’t seen
anyone… very little contact… not even talks on the
telephone (P8).
The severity of their illness and the profound disabilities
also had a negative impact on the ability to fulfil the role
of mother/father, partner or colleague:
You don’t feel like a sexy lady when you just burp and
fart all the time, have pain, and you just want not to
be touched. I had guilty conscience towards my
partner because I couldn’t attend anything, not be
social or having a sexual relationship (P10); Your
partner gets a double duty (P11); ‘Can you go skiing
with us now, daddy?’ But I’m unable to do it (P15);
I don’t suffice as a colleague at work (P24).
Phase 4: experiences of the upward phase of PIFS
Several experiences indicated that the improvement
phase had started, such as fewer symptoms, less need for
rest, increased functional ability and more energy. The
overall improvement in functional ability during the
upward phase was described as slow, and relapses could
still occur. Most participants were able to resume some
household chores or go for a walk, because they could
sustain slightly more activity:
[I’ve] gradually started to become better. It’s a long
time since I have had any crashes (P1); [C]ould
gradually sustain slightly more physical activity (P9).
The cognitive disability had lessened somewhat, but to
varying degrees. The ability to concentrate, read, converse
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and communicate with others improved gradually. Partici-
pants who had been severely ill and “beyond time” at their
worst now experienced more energy, allowing emotions to
re-occur. Boredom was seen as a sign of improvement:
I feel that my brain functions a lot better [now]…
suddenly I became aware of it… have enough energy
to read what I'm interested in, in the newspaper (P13);
I’ve had concentration problems… have improved
somewhat (P9); I felt for the first time since I became
ill… boredom… a sign of improvement (P19).
Most participants were gradually able to endure
slightly more sensory stimuli, and intolerances to foods
and alcohol had lessened, but not for everyone. A few
continued to be very sensitive to light and noise and
used blackout curtains and ear protection gear:
I feel that I gradually can tolerate more [alcohol]
(P16); [I could] slightly tolerate more sensory input…
listen to the radio again… watch some television…
half an hour in the evening (P9); Spicy food I can’t eat
if I’m drained of energy, but on a very good day (P20).
Most participants were now able to slightly increase
participation in social and cultural events and to recon-
nect with friends:
I feel I can resume a form of social contact that I’ve put
on ice. I now feel that I could book tickets to the music
festival… because I’m starting to get better (P13); [A]
little contact with friends by email and possibly
telephone (P23); Just that I can talk with people,
discuss… keep up, that gives me a lot now (P16).
Some participants experienced improvement in func-
tional ability:
I had full-time sick leave… probably a year passed
before I resumed working 20%… for quite a long time,
then increased to 40% (P1); [I] feel that my health has
improved. I envision that I might be able to start
working again (P13).
Phase 5: experiences of the chronic phase of PIFS
Following a period of more or less improvement in
functional ability, most participants experienced reaching a
more stable situation, suggesting that a chronic phase had
been reached. Whereas a few hardly improved from their
worst period of disability during the turning phase and
continued to be severely disabled into the chronic phase,
others experienced improvement in various degrees. A
new decline after some improvement also occurred.
After four years, six women and four men (38%),
were able to work 20–50% or to study part time and
were only partly dependent on welfare benefits. The
majority, 13 women and 3 men (62%), were unable to
work or study and therefore fully dependent on
welfare benefits:
Now it’s fifty-fifty for me when I’m working 50%…
50% welfare benefits (P26); I’m much better… at
school six hours every day, max (P16).
Participants experienced that some symptoms had
abated, whilst others remained the same. Many still
suffered from irritable bowel complaints:
The recent weeks have been the best in a long
time… Now I sleep 10, 11 hours instead of 14 (P4);
The symptom intensity has abated… but I [still]
have many symptoms (P1); Stomach pain, diarrhoea
and sweating all day… my body trembles, headache
and my stomach growls, flatulence (P20).
The participants continued struggling to find their bod-
ies’ capacity limits but sometimes pushed themselves too
hard, provoking short-time relapses. They experienced the
fluctuating nature of the functional ability in daily life as
challenging. When the functional and energy levels im-
proved, there was still a risk of pushing oneself too much:
[I] could improve for a while, and then maybe I
pushed too much, and then there were other things
that certainly provoked setbacks and I could get worse
again (P9).
Most participants also experienced that their cognitive
function had improved. They described that the physical
and cognitive functions were interrelated and varied
according to overall functional level:
Today I have Alzheimer’s (P20); Still I have no
memory. What happened last week, it’s gone… If I
don’t have papers with me, then I remember nothing
(P10); The cognitive also has become very much
better (P17); I’ve resumed studying… a bachelor’s
program (P14); I improved physically before I
improved cognitively (P19).
With increased energy levels, most participants were
able to see friends and take more part in social and cul-
tural activities:
Now, when I’ve got some energy, I’ll make contact
[with friends] again (P11); I've been abroad… weekend
trips with friends two, three days (PT).
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One of the participants did not experience much im-
provement and continued to be severely affected in the
chronic phase:
I’ve been homebound, lying down most of the time.
The last three years have passed as one… doing
absolutely nothing. [E]ven if I use blackout curtains,
I need to wear eye protection. A flash of light is too
much…I get worse from any concentration…
watching TV or reading… starting to cold sweat and
feeling dizzy (P23).
None of the participants achieved working/studying
capacity beyond 50% of their pre-illness functional level.
A few experienced a new decline after a period of im-
provement. They either had to keep working to provide
for their family because the social security system did
not grant them enough support, or they continued
working in an attempt to regain normalcy, resulting in
dropout from work:
[T]oday I’m more ill than I was when I started getting
back to work (P5); I’m on disability benefits (P20); I’ve
become weaker and weaker… much more fatigued,
walk like a zombie at home (P10).
Nor did anyone experience regaining their pre-illness
functional abilities. Fatigue, lack of energy and poor stam-
ina made some feel old before their time: “I feel like an
octogenarian” (P10). Some worried whether they would
ever work again: “Will I get back to work? Is this how my
life will be for the rest of my life? (P22). Regardless of their
functional levels, the participants experienced an overall
positive view of their future and strongly wished to regain
their health. The future was perceived to be uncertain, as
they were aware of the risk of overdoing and relapses:
[It is an] uncertain world, [I] live from day to day
(P10); I hope I’ll have steady progress and still get
better, that this doesn’t stop now (P16).
At this point in time they had more experience with
their bodies’ limitations and had altered their perspective:
Work is an important part of my identity, but I can’t
spend so much energy at work that I don’t have
energy enough to my family at home. I've realized it. I
am conscious that I have to share the energy between
my job and my family because they are equally
important (P26).
The participants’ self-rated functional levels
The participants had retrospectively rated their ability to
function at some points in time on Bell’s 10-point
disability grading scale [43], a scale ranging from 0 to
100 [see Additional file 2]. 100 = no symptoms with ex-
ercise; normal overall activity; able to work or do house/
home work full time with no difficulty and 0 = severe
symptoms on a continuous basis; bedridden constantly;
unable to care for self. The median score for both
genders was 100 prior to contracting the infection; this
was in agreement with the background data. The nadir
median score for women was 20: moderate to severe
symptoms at rest; unable to perform strenuous activity;
overall, activity levels are 30–50% of expected; unable to
leave the house except rarely; confined to bed most of
the day; unable to concentrate for more than 1 h/day.
The nadir median score for men was 10: severe symp-
toms at rest; bedridden the majority of the time; no
travel outside of the house; marked cognitive symptoms
preventing concentration. The median score for both
genders prior to the interviews in 2008 was 40: moderate
symptoms at rest; moderate to severe symptoms with
exercise activity; overall activity level 50–70% of ex-
pected; not confined to house; unable to perform strenu-
ous duties; can perform light duty/desk work 3–4 h/day;
requires rest periods. The median patterns of changes in
disability seems quite similar for both genders, although
the median score for men was slightly lower than for
women in the fall of 2007. The downward phase com-
prises both the prodromal phase and the first phase of
PIFS, that is, from good health in the spring of 2004 to
the nadir of the illness trajectory. Our intention is not to
present correlational statistics in this qualitative study,
but only to present median disability scores for both
genders (Fig. 2) and individual disability scores (Fig. 3)
as complementary sources for visualising the perceived
disability at different points in time.
The participants’ scores at different points in time
indicate that they experienced individual illness trajec-
tories, a finding that corresponded with their illness
accounts. To illustrate the different trajectories among
the participants, a plot of their scores is presented
(Fig. 3). Five of the 26 participants with missing values
were excluded. Participant 14 scored 100 at time point
4, indicating full recovery. At the same time, this partici-
pant reported 52 symptoms and was dependent on 50%
welfare benefits, which is more consistent with a
reduced functional level than full health.
Discussion
The aim of this study was to explore illness trajectory and
concomitant disabilities. When exploring how persons
with PIFS experienced the first four years of their condi-
tion we identified five distinct progressive phases of the
illness and disability trajectory: prodromal, downward,
turning, upward and chronic phase (PIFS Disability Model
[PIFSDM]). These phases have parallels to the four-
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phased Fennel Phase Inventory (FPI) of progressive
psychological coping spanning the physical, psychological,
social and workplace performance aspects of living [32].
However, our study contributed with new knowledge by
focusing on the in-depth experiences of the illness phases,
specifically the fluctuations in functional abilities, including
physical, cognitive, emotional, neurological, intolerances,
vocation/studying, role performance, symptom burden,
and fatigue severity. From the retrospective accounts, we
were able to untangle variations in the experienced severity
of the disabilities over four years. Disabilities may comprise
physical, intellectual, cognitive, emotional, sensory and
neurological impairments, or any combination of these
[67], and all of these were applicable to persons in our
sample.
Whereas previous research found that fatigue and pain
severity seemed to be the same across the phases of
chronic fatigue syndrome (CFS) [68], our findings indi-
cate that for persons with PIFS, the symptom severity
may vary in different phases. Our participants described
that fatigue increased during the downward phase and
that it was at its worst during the turning phase; for
some, the fatigue abated during the upward and chronic
phases.
Most of the participants felt they were continuing to
improve their functional abilities during the upward and
chronic phases. However, a few participants perceived
that their functional levels remained almost the same
from the turning phase and onward. Others experienced
some improvement, but then a new decline in functional
abilities occurred during the chronic phase, apparently
related to over-engagement in work-related roles. The
chronic phase showed different forms, and as seen in
CFS populations [33, 34], regression occurred. CFS and
PIFS are relapsing and remitting conditions, and both
FPI and PIFSDM describe regression to an earlier phase
when relapse occurs, or a new decline in functional abil-
ity may take place in the chronic phase. In addition,
Fig. 2 The participants’ perceived disability levels at different points
in time* (n = 26). *Changes in ability to function during the illness
trajectory were retrospectively self-rated on Bell’s Disability Scale in
January 2008, before the interview. The point in time when the ability
to function in everyday life reached its nadir differed among the
participants occurred sometime between 2004 and 2007, thus not
specified in the figures
Fig. 3 Individual illness trajectories as experienced by 21 of 26 participants. *The x-axis shows disability levels on Bell’s Disability Scale from 0–100.
The y-axis displays points in time of measurement. The number on top of the individual trajectories is consistent with the patient ID number that
corresponds with the participant number attached to the quotes (ID no. 1 = P1 etc.)
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there is overlap between the phases. The FPI is a system
model where sociocultural factors play a significant role
in the coping process, whereas the focus of PIFSDM is
on how the participants experience their fluctuating abil-
ity to function in daily life. The FPI and our PIFSDM
may serve as complementary sources to understand how
the condition affects the everyday experiences of persons
who live with it and to provide tools for assessments and
treatments.
The participants exceeded their capacity limits, espe-
cially during the first phases. Ramsey noted during the
outbreaks in the 1950s and later that affected individuals
for whom rest was enforced when they fell ill had the
best prognosis [69, 70]. This suggests that a faster pro-
gression to the turning and upward phases may contrib-
ute to less severe disabilities and facilitate improvement.
Our participants associated continued full-time work
or studies for longer periods of time with higher levels
of disability during the downward phase. Although this
study cannot establish causal relationships, their experi-
ences suggest that they might have needed help to en-
sure adequate rest early on to limit further deterioration.
The participants described that the chronic phase could
take many forms such as deterioration, no improvement
and varying degrees of improvement. This is in line with
previous findings [27, 70, 71].
Although the degree of severity and symptom burden
differed among our participants, the interview data did
not indicate that any of the background factors seemed
to significantly influence the illness trajectory or types of
disabilities. Our sample is consistent with the Giardia
PIFS cohort study [4] regarding high education levels
and high levels of disability, and is also consistent with
other study samples regarding demographic characteris-
tics such as education level, age and gender [2, 72, 73].
Independently of gender, age and educational level, the
participants experienced the same trajectory of five
phases. In our qualitative study it is not possible to know
to what degree those or other variables impacted the se-
verity of the disabilities in each phase or why some de-
veloped PIFS within a short time, whereas in others this
development took a much longer time. That the time to
develop PIFS varied, was also found in the Giardia PIFS
cohort [4]. However, low income seemed to add to the
burden and forced participants to push themselves to
work in order to survive, resulting in an emotionally
draining situation and lack of rest, followed by symptom
flare-ups and increased disability that may have ham-
pered improvement [74].
All fatigue is not the same [75, 76], and the time to
reach a diagnosis may take years. Contextual factors
such as lack of knowledge and trivializing the partici-
pants’ symptoms may have caused diagnostic delay that
may have had a negative influence on the prognosis. The
participants struggled on their own, had no knowledge
of what was wrong with them and thus chose many
counterproductive actions that made them worse. Early
recognition of the illness experience, trajectory and vari-
ous disabilities accompanying PIFS may be considered
as a key factor for GPs and other health care providers
who will be able to provide more appropriate advice on
how to master the condition and its implications and
offer symptom alleviation at an earlier stage. An early
diagnosis for the persons affected with PIFS is also im-
portant because they will be able to understand what is
wrong with them and early on find the best ways deal
with their illness and disabilities to improve their health
and ability to function, or regain pre-illness life.
The chance to regain full health after PIFS is slim, es-
pecially after being ill for more than two years [27]. Just
when the illness trajectory progresses from an upward
trend into a chronic phase is difficult to establish, as the
transition may be imperceptible and biomarkers are
lacking. A recent study found that the early-altered
immune signature of both pro- and anti-inflammatory
cytokines changed after three years [77], a factor that
may indicate the transition to a chronic phase. Our find-
ings of an overall phased illness trajectory and that the
participants experienced a natural turning phase sug-
gests a natural course of PIFS.
The variations in illness levels and trajectories compel
us to concur with the notion that determining accurate
prognosis of recovery on an individual level is not pos-
sible due to lack of biomarkers and a poorly understood
aetiology [78]. In line with our findings, differences in
functional ability and improvement remain several years
after the triggering event [79], as do high rates of drop-
out from work [27, 80] and reliance on disability benefits
[28, 29]. Our findings that some of the participants were
able to work or study part time concur with previous re-
ports [4, 27].
Giardia l. as a triggering agent has been suspected
before [81], and a prodromal phase of gastroenteritis has
been documented [13]. New intolerances to foods,
alcohol and sensory stimuli have also been reported
previously [13, 82] as have periods of hypersomnia [83]
and a fluctuating pattern [13].
To our knowledge, this is the first qualitative study
that explores the experienced illness trajectory of PIFS
following a confirmed infection. The participants’ expe-
riences add an important lifeworld perspective to the
pathophysiological underpinnings and to quantitative
studies on functional status that show that functional
capacity is significantly lower than the general popula-
tion or other disease comparison groups [84–86].
Persons with this condition experience serious impacts
on their personal and professional life [87], but their
needs are not being met [88]. Health care providers need
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more knowledge of the possibility for developing PIFS
after infections, the characteristics of PIFS and its func-
tional trajectory. It is important to identify the different
phases when assessing the individual’s need for help and
considering treatment options. Enhanced knowledge on
the part of health care providers may result in earlier
diagnoses, better prognoses [89], more appropriate ad-
vice on how to treat or manage this condition and avoid-
ance of confusion between PIFS-associated fatigue and
depression [90]. Practical assistance, granted absence
from work or studies, financial support and other means
of help to promote health need to be considered.
Because PIFS patients have complex needs, timely and
tailored treatments and support from an interdisciplin-
ary team would help if these patients are to regain or
improve functional abilities [91]. Early diagnosis and ap-
propriate help may limit the disabilities following PIFS
and may facilitate improvement.
Strengths and limitations
The strengths of this study are the relatively large quali-
tative maximum variation sample, a confirmed infectious
trigger, and that participants were not recruited from
support groups that may confer biases in terms of spe-
cial attitudes or views on, or a joint understanding of,
the condition. However, our study has several limita-
tions. Although we used maximum variation sampling,
this is a sample recruited from the Giardia PIFS cohort
at one medical centre at one point in time. Our sample
might therefore not be representative for all PIFS popu-
lations. The high education and disability levels found in
our study are consistent with those found in the larger
Giardia PIFS cohort study. Moreover, the frequency of
higher education levels, gender distributions and demo-
graphics are consistent with other research samples, but
our sample may differ on other variables not examined
in our study. The participants reported memory gaps;
therefore, they may have forgotten experiences pertain-
ing to the study’s purpose. A retrospective interview is
open to memory bias and may reflect the participants’
conceptualisation of their experiences at the time of the
interview rather than capturing their views when the
experiences actually occurred. However, our findings
correspond with previous research and therefore may be
applicable to other PIFS cases or cases with ME. Because
the condition is heterogeneous, our findings may not be
applicable to all cases or subgroups, or population-based
samples.
Conclusions
Our in-depth qualitative analysis showed a phased illness
trajectory and variations in disabilities among the partic-
ipants. None of the participants in our qualitative study
had experienced full remission, pre-illness functional
level, or experienced a good outcome. Some were, how-
ever, able to work half-time because they rested between
working days. These findings are consistent with the
Giardia PIFS cohort study. Bell’s Disability Scale offered
a visual and complementary source of information about
the illness trajectory, as it corresponds with the partici-
pants’ own accounts. These accounts revealed severe
multiple disabilities that made it challenging for the
participants to communicate with others, fulfil roles,
participate in social events, learn new things, keep work-
ing/studying and regain their health and pre-illness func-
tional levels. These multiple disabilities severely disrupted
the participants’ capacity to function in personal and
professional life. Further research is warranted to ex-
plore the relevance of the PIFSDM in other popula-
tions of persons with PIFS and to explore different
treatment options at different phases. Prospective,
longitudinal studies should be conducted to uncover
the experiences of persons as they unfold. A compari-
son of the functional trajectory in PIFS cases and
cases with an unknown trigger mechanism would be
helpful to identify any differences in trajectories.
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